RFI Lupus Research Program (LRP) Public
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEFENSE HEALTH AGENCY
Contract Value
Not provided
Codes & Classification
Solicitation Number
HT9427RFI2027LRP
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Classification Code
-
Additional Details
Documents2
The Defense Health Agency (DHA), operating under the Department of Defense, has issued a Sources Sought notice (Procurement Identifier: HT9427RFI2027LRP) seeking input to inform the future direction of the Lupus Research Program (LRP) administered by the Congressionally Directed Medical Research Programs (CDMRP). This Request for Information (RFI) is intended to gather feedback from a broad spectrum of stakeholders—including academia, industry, community and non-profit organizations, scientific and professional organizations, federal agencies, and the general public—to help shape potential focus areas and research funding opportunities for the LRP in fiscal year 2027 (FY27) and beyond.
The LRP is dedicated to advancing research that aims to understand, prevent, and diagnose lupus, as well as to improve treatments and the quality of life for patients, including Service Members, their families, Veterans, and the general public. The program’s vision is to cure lupus through collaborative partnerships among scientists, clinicians, and those affected by the disease. Since its inception, the LRP has received appropriations totaling $75 million from FY17 through FY24 and FY26. As of October 2026, funding for FY27 has not yet been appropriated; this RFI is strictly for information and planning purposes and does not constitute a solicitation or a commitment by the LRP or the Department of Defense.
The place of performance for this initiative is Frederick, Maryland, and the relevant NAICS code is 541714, which covers Research and Development in Biotechnology (except Nanobiotechnology). The contracting entity is the Defense Health Agency, a federal office within the Department of Defense.
Interested parties are encouraged to respond to the RFI by submitting feedback via the provided SurveyMonkey link (https://www.surveymonkey.com/r/FY27-LRP-RFI) by November 16, 2026. Responses will be used to support program planning and may influence future funding opportunities and research priorities. For further information, the primary point of contact is Jared D. Acre, who can be reached at [email protected] or 301-619-9033. Additional details about the LRP and its review process are available at https://cdmrp.health.mil/lrp/ and https://cdmrp.health.mil/about/2tierRevProcess.
This notice remains active and is accessible via SAM.gov (Opportunity ID: 9b5fc5bc620e40e49b0955fc2b536840). Contractors and organizations with expertise in biotechnology research related to lupus are encouraged to review the opportunity and consider providing input to help shape the future of lupus research funded by the CDMRP.